Marimed (MRMD) Receivables - Net (2016 - 2025)
Marimed (MRMD) has disclosed Receivables - Net for 14 consecutive years, with $9.4 million as the latest value for Q4 2025.
- Quarterly Receivables - Net rose 7.54% to $9.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.4 million through Dec 2025, up 7.54% year-over-year, with the annual reading at $9.4 million for FY2025, 7.54% up from the prior year.
- Receivables - Net for Q4 2025 was $9.4 million at Marimed, up from $8.0 million in the prior quarter.
- The five-year high for Receivables - Net was $9.4 million in Q4 2025, with the low at $1.7 million in Q4 2021.
- Average Receivables - Net over 5 years is $6.9 million, with a median of $7.3 million recorded in 2021.
- The sharpest move saw Receivables - Net plummeted 75.04% in 2021, then skyrocketed 425.81% in 2022.
- Over 5 years, Receivables - Net stood at $1.7 million in 2021, then surged by 425.81% to $8.8 million in 2022, then decreased by 17.82% to $7.2 million in 2023, then rose by 21.43% to $8.7 million in 2024, then grew by 7.54% to $9.4 million in 2025.
- According to Business Quant data, Receivables - Net over the past three periods came in at $9.4 million, $8.0 million, and $7.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.